Work

Vorinostat (VOR) and capecitabine (CAP) in recurrent and/or metastatic squamous cell carcinoma of head and neck (RMHNSCC): A study of the Princess Margaret Phase II Consortium.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e17001

Authors: Eric Xueyu Chen, Eric Winquist, Cheryl Ho, Barbara Jennifer Gitlitz, James Ohr, Albiruni R. A. Razak, Lillian L. Siu, James A. Zwiebel, Amit M. Oza, Lisa Wang, Soo Chin, Anne Malpage, Carleen Yu, Edward Mejia, Lori Gevaudan, Prachi Mohite

Institutions: Princess Margaret Cancer Centre, London Health Sciences Centre, BC Cancer Agency, USC Norris Comprehensive Cancer Center, University of Pittsburgh, University Health Network, National Cancer Institute, University of Southern California, University of Pittsburgh Medical Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907545504

Cites:

Cited by: 2

Related to: 10